申请人:Perez Lawrence Blas
公开号:US20090306107A1
公开(公告)日:2009-12-10
The present invention relates to compounds that are useful to inhibit, regulate and/or modulate tyrosine and serine/threonine kinase and kinase-like proteins, such as RAF kinase, a serine/threonine kinase that functions in the MAP kinase signaling pathway. The application is also concerned with compositions which contain these compounds, and methods of using them to treat tyrosine and serine/threonine kinase and kinase-like dependent diseases, such as angiogenesis, cancer and cardiac hypertrophy, and with other subject matter.
本发明涉及化合物,这些化合物可用于抑制、调节和/或调节酪氨酸和丝氨酸/苏氨酸激酶和激酶样蛋白,例如RAF激酶,一种在MAP激酶信号通路中发挥作用的丝氨酸/苏氨酸激酶。该申请还涉及包含这些化合物的组合物,以及使用它们治疗酪氨酸和丝氨酸/苏氨酸激酶和激酶样依赖性疾病的方法,例如血管生成、癌症和心脏肥大,以及其他主题。